These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 23717871)

  • 21. Inhibition of human platelet glycoprotein IIB/IIIA binding to fibrinogen by tumor cell membrane proteins.
    Kamiyama M; Chen K; Lynch J; Arkel YS
    Cancer Res; 1993 Jan; 53(2):221-3. PubMed ID: 8417811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-podoplanin Monoclonal Antibody LpMab-7 Detects Metastatic Lesions of Osteosarcoma.
    Kaneko MK; Oki H; Ogasawara S; Takagi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):154-61. PubMed ID: 26090592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibodies to Factor XII and Kininogen-Dependent Antiphosphatidylethanolamine Antibodies in Patients with Recurrent Pregnancy Loss Augment Platelet Aggregation.
    Sato Y; Sugi T; Sakai R
    Am J Reprod Immunol; 2015 Sep; 74(3):279-89. PubMed ID: 26011374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A monoclonal antibody to platelet glycoprotein IIb induces aggregation of platelet rich plasma.
    Perutelli P; Marchese P; Mori PG
    Haematologica; 1990; 75(2):187-90. PubMed ID: 2358207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of chronic ITP in children and adolescents.
    Nilsson C; Tedgård U; Ljung R
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):660-1. PubMed ID: 16933245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma.
    Suzuki H; Kato Y; Kaneko MK; Okita Y; Narimatsu H; Kato M
    FEBS Lett; 2008 Jan; 582(2):341-5. PubMed ID: 18158922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Stable expression of recombinant human podoplanin in Chinese hamster ovary (CHO) cells].
    Qu L; Zhao X; Fu J; Xia L; Dai L; Ruan C; Zhao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jan; 32(1):25-8. PubMed ID: 26728373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Identification of the novel platelet activation receptor CLEC-2 and Its pathological and physiological roles].
    Suzuki Inoue K; Inoue O; Ozaki Y
    Rinsho Byori; 2010 Dec; 58(12):1193-202. PubMed ID: 21348239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of platelet activation induced by HLA antibodies associated with alloimmune thrombocytopenia.
    Christie DJ; Leja DN; Carlson DL; Swinehart CD
    J Lab Clin Med; 1993 Mar; 121(3):437-43. PubMed ID: 7680369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Podoplanin immunostaining in cutaneous apocrine carcinoma and in cutaneous metastasis from the breast.
    Fernandez-Flores A
    Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):573-4. PubMed ID: 20697264
    [No Abstract]   [Full Text] [Related]  

  • 32. The novel platelet activation receptor CLEC-2.
    Suzuki-Inoue K; Inoue O; Ozaki Y
    Platelets; 2011; 22(5):380-4. PubMed ID: 21714702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-Amyloid protein induces platelet aggregation and supports platelet adhesion.
    Kowalska MA; Badellino K
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1829-35. PubMed ID: 7811271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Both complement- and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor B.
    Miajlovic H; Loughman A; Brennan M; Cox D; Foster TJ
    Infect Immun; 2007 Jul; 75(7):3335-43. PubMed ID: 17438032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization.
    Matsumoto Y; Takizawa H; Gong X; Le S; Lockyer S; Okuyama K; Tanaka M; Yoshitake M; Tandon NN; Kambayashi J
    Thromb Res; 2007; 119(3):319-29. PubMed ID: 16566959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoinhibition of ristocetin-induced platelet aggregation.
    Nachman RL; Jaffe EA; Weksler BB
    J Clin Invest; 1977 Jan; 59(1):143-8. PubMed ID: 299747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of platelet aggregation induced by HLA-related antibodies.
    Brandt JT; Julius CJ; Osborne JM; Anderson CL
    Thromb Haemost; 1996 Nov; 76(5):774-9. PubMed ID: 8950789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
    Kleiman NS; Raizner AE; Jordan R; Wang AL; Norton D; Mace KF; Joshi A; Coller BS; Weisman HF
    J Am Coll Cardiol; 1995 Dec; 26(7):1665-71. PubMed ID: 7594101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EMILIN2 regulates platelet activation, thrombus formation, and clot retraction.
    Huang M; Sannaningaiah D; Zhao N; Gong Y; Grondolsky J; Hoover-Plow J
    PLoS One; 2015; 10(2):e0115284. PubMed ID: 25658937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characterization of platelet aggregation-inducing factor podoplanin and development of its antibodies].
    Kato Y
    Seikagaku; 2013 Apr; 85(4):261-5. PubMed ID: 23717871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.